Literature DB >> 15466887

Demonstration of BACE (beta-secretase) phosphorylation and its interaction with GGA1 in cells by fluorescence-lifetime imaging microscopy.

Christine A F von Arnim1, Michelle M Tangredi, Ithan D Peltan, Bonny M Lee, Michael C Irizarry, Ayae Kinoshita, Bradley T Hyman.   

Abstract

beta-Secretase (BACE) carries out the first of two proteolysis steps to generate the amyloid-beta peptides that accumulate in the senile plaques in Alzheimer's disease (AD). Because most BACE activity occurs in endosomes, signals regulating its trafficking to these compartments are important to an understanding of AD pathogenesis. A DISLL sequence near the BACE C-terminus mediates binding of BACE to the VHS domains of Golgi-localized gamma-ear-containing ARF-binding (GGA) proteins, which are involved in the sorting of proteins to endosomes. Phosphorylation of the motif's serine residue regulates BACE recycling back to the cell surface from early endosomes and enhances the interaction of BACE with GGA proteins in isolated protein assays. We found that BACE phosphorylation influences BACE-GGA interactions in cells using a new fluorescence-resonance-energy-transfer-based assay of protein proximity, fluorescence lifetime imaging. Although serine-phosphorylated BACE was distributed throughout the cell, interaction of GGA1 with the wild-type protein occurred in juxtanuclear compartments. Pseudo-phosphorylated and non-phosphorylated BACE mutants remained localized with GGA1 in the Golgi body, but the latter mutation diminished the two proteins' FRET signal. Because BACE phosphorylated at serine residues can be identified in human brain, these data suggest that serine phosphorylation of BACE is a physiologically relevant post-translational modification that regulates trafficking in the juxtanuclear compartment by interaction with GGA1.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15466887     DOI: 10.1242/jcs.01422

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  47 in total

Review 1.  Inhibition of BACE1 for therapeutic use in Alzheimer's disease.

Authors:  Xiaoyang Luo; Riqiang Yan
Journal:  Int J Clin Exp Pathol       Date:  2010-07-08

2.  Mac-1 promotes FcgammaRIIA-dependent cell spreading and migration on immune complexes.

Authors:  Ying Xiong; Chunzhang Cao; Alexandra Makarova; Brad Hyman; Li Zhang
Journal:  Biochemistry       Date:  2006-07-25       Impact factor: 3.162

Review 3.  Sorting through the cell biology of Alzheimer's disease: intracellular pathways to pathogenesis.

Authors:  Scott A Small; Sam Gandy
Journal:  Neuron       Date:  2006-10-05       Impact factor: 17.173

4.  Ubiquitin regulates GGA3-mediated degradation of BACE1.

Authors:  Eugene L Kang; Andrew N Cameron; Fabrizio Piazza; Kendall R Walker; Giuseppina Tesco
Journal:  J Biol Chem       Date:  2010-05-18       Impact factor: 5.157

Review 5.  Protein phosphatases and Alzheimer's disease.

Authors:  Steven P Braithwaite; Jeffry B Stock; Paul J Lombroso; Angus C Nairn
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

6.  Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein.

Authors:  Olav M Andersen; Juliane Reiche; Vanessa Schmidt; Michael Gotthardt; Robert Spoelgen; Joachim Behlke; Christine A F von Arnim; Tilman Breiderhoff; Pernille Jansen; Xin Wu; Kelly R Bales; Roberto Cappai; Colin L Masters; Jørgen Gliemann; Elliott J Mufson; Bradley T Hyman; Steven M Paul; Anders Nykjaer; Thomas E Willnow
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-07       Impact factor: 11.205

7.  Retrieval of the Alzheimer's amyloid precursor protein from the endosome to the TGN is S655 phosphorylation state-dependent and retromer-mediated.

Authors:  Sandra I Vieira; Sandra Rebelo; Hermann Esselmann; Jens Wiltfang; James Lah; Rachel Lane; Scott A Small; Sam Gandy; Edgar F da Cruz E Silva; Odete Ab da Cruz E Silva
Journal:  Mol Neurodegener       Date:  2010-10-11       Impact factor: 14.195

Review 8.  BACE and gamma-secretase characterization and their sorting as therapeutic targets to reduce amyloidogenesis.

Authors:  Neville Marks; Martin J Berg
Journal:  Neurochem Res       Date:  2009-09-17       Impact factor: 3.996

9.  Inhibition of GSK3β-mediated BACE1 expression reduces Alzheimer-associated phenotypes.

Authors:  Philip T T Ly; Yili Wu; Haiyan Zou; Ruitao Wang; Weihui Zhou; Ayae Kinoshita; Mingming Zhang; Yi Yang; Fang Cai; James Woodgett; Weihong Song
Journal:  J Clin Invest       Date:  2012-12-03       Impact factor: 14.808

10.  The Basic Biology of BACE1: A Key Therapeutic Target for Alzheimer's Disease.

Authors:  S L Cole; R Vassar
Journal:  Curr Genomics       Date:  2007-12       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.